+Search query
-Structure paper
Title | The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 55, Page 6523-6540, Year 2012 |
Publish date | Jun 20, 2012 (structure data deposition date) |
Authors | Lewis, R.T. / Bode, C.M. / Choquette, D.M. / Potashman, M. / Romero, K. / Stellwagen, J.C. / Teffera, Y. / Moore, E. / Whittington, D.A. / Chen, H. ...Lewis, R.T. / Bode, C.M. / Choquette, D.M. / Potashman, M. / Romero, K. / Stellwagen, J.C. / Teffera, Y. / Moore, E. / Whittington, D.A. / Chen, H. / Epstein, L.F. / Emkey, R. / Andrews, P.S. / Yu, V.L. / Saffran, D.C. / Xu, M. / Drew, A. / Merkel, P. / Szilvassy, S. / Brake, R.L. |
External links | J. Med. Chem. / PubMed:22734674 |
Methods | X-ray diffraction |
Resolution | 1.7 - 2 Å |
Structure data | PDB-4fob: PDB-4foc: PDB-4fod: |
Chemicals | ChemComp-0US: ChemComp-HOH: ChemComp-0UU: ChemComp-0UV: ChemComp-GOL: |
Source |
|
Keywords | Transferase/Inhibitor / receptor tyrosine kinase / inhibitor / crizotinib / neuroblastoma / CD246 / phosphotransferase / NPM-ALK / EML4-ALK / in situ proteolysis / Transferase-Inhibitor complex |